Immuron (IMRN) Debt Ratio (2016 - 2023)

Immuron (IMRN) posted quarterly Debt Ratio of 24.54 for Q2 2023, up 4922.07% quarter-over-quarter from 0.49 in Q2 2020.

Immuron (IMRN) Debt Ratio (2016 - 2023) Analysis & Trends

Immuron's Debt Ratio history runs 5 years deep, the most recent figure standing at 24.54 for Q2 2023.

In Q2 2023, Debt Ratio changed N/A year-over-year to 24.54; the TTM figure through Jun 2023 stood at 24.54 (changed N/A YoY), while the FY2020 annual figure was 0.0, down 99.9% from the prior year.
Debt Ratio for Q2 2023 stood at 24.54, up from 0.49 in the prior quarter.
The five-year high for Debt Ratio was 24.54 in Q2 2023, with the low at 0.49 in Q2 2020.
The 3-year median for Debt Ratio is 1.89 (2019), against an average of 7.2.
Peak annual rise in Debt Ratio reached 20.41% in 2020, while the deepest fall reached 20.41% in 2020.
Immuron's Debt Ratio stood at 3.16 in 2019, then sank by 84.56% to 0.49 in 2020, then surged by 4922.07% to 24.54 in 2023.
Business Quant data shows IMRN's Debt Ratio at 24.54 in Q2 2023, 0.49 in Q2 2020, and 3.16 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.05
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.03
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.47
10	Immuron	6.75 Mn	6.73 Mn	-	-

Download Data